Stock-Based Compensation Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Shares
Outstanding Beginning Balance (in shares)	217,519		217,519
Exercised (in shares)	(95,019)	(50,000)	(95,019)	(54,481)
Outstanding Ending Balance (in shares)	162,500		162,500
Grants in period	40,000		40,000
Exercisable at end of period (in shares)	122,500		122,500
Weighted-Average Exercise Price
Outstanding Beginning Balance (in dollars per share)	$ 11.20		$ 11.20
Granted (in dollars per share)	12.06		12.06
Exercised (in dollars per share)	10.78		10.78
Outstanding Ending Balance (in dollars per share)	$ 11.65		$ 11.65
Exercisable at end of period, Weighted Average Exercise Price (in dollars per share)	11.52		11.52
Weighted-Average Remaining Contractual Term in Years
Outstanding Ending Balance (in years)	3 years 4 months 24 days		3 years 4 months 24 days
Exercisable at end of period, Weighted Average Remaining Contractual Term in Years	1 year 3 months 18 days		1 year 3 months 18 days
Aggregate Intrinsic Value
Outstanding Beginning Balance	$ 104,584		$ 823,028
Granted	0		0
Exercised	114,438		114,438
Outstanding Ending Balance	186,025		186,025
Exercisable at end of period, Aggregate Intrinsic Value	$ 159,625		$ 159,625
Share Based Compensation, Stock Option Plan, Additional Disclosures [Abstract]
Nonvested Beginning Balance, Weighted-Average Grant Date Fair Value (in dollars per share)	$ 4.10		$ 4.10
Granted, Weighted-Average Grant Date Fair Value (in dollars per share)	2.98		2.98
Exercised, Weighted Average Grant Date Fair Value (in dollars per share)	3.85		3.85
Nonvested Endingg Balance, Weighted-Average Grant Date Fair Value (in dollars per share)	3.98		3.98
Exercisable at end of period, Weighted Average Grant Date Fair Value (in dollars per share)	$ 4.30		$ 4.30
Vested and expected to vest assuming a 3% forfeiture rate over the vesting term
Shares
Expected to Vest (in shares)	161,300		161,300
Weighted-Average Exercise Price
Expected to Vest, Weighted Average Exercise Price (in dollars per share)	$ 11.65		$ 11.65
Weighted-Average Remaining Contractual Term in Years
Remaining weighted average vesting period	3 years 4 months 6 days		3 years 4 months 6 days
Aggregate Intrinsic Value
Expected to Vest, Aggregate Intrinsic Value	$ 185,233		$ 185,233
Share Based Compensation, Stock Option Plan, Additional Disclosures [Abstract]
Expected to Vested, Weighted Average Grant Date Fair Value (in dollars per share)	$ 3.99		$ 3.99